Review Process
The 2026 dates for reviewing UKMED research outputs are:
| Review Type Submission Deadline | Feedback Date | |
|---|---|---|
| Remote | 02 August 2026 9:00 GMT | w/c 23 August 2026 |
| In-person | 16 October 2026 09:00 GMT | w/c 6 December 2026 |
Please submit final reports to info@ukmed.ac.uk.
Please note that remote reviews are now being conducted to increase opportunities for publication. However, if reviewers are unable to reach a consensus, the paper will instead be deferred for review at the next in-person meeting.
Researchers must submit a final report to the UKMED team before the submission deadline for it to be appraised before the review date. Following the review, the outcome from the Research Subgroup will be communicated to the UKMED researcher after the feedback date.
Types of reviews
The Research Subgroup will consider reviewing the following outputs:
- Final Reports, where the submitted report is intended for journal publication; and
- Interim Reports, where preliminary findings are intended for presentation at a conference (e.g., abstract or poster). Please note that if you plan to present findings at a conference or via a poster, an interim report must be submitted for review. UKMED does not approve standalone abstracts for these purposes.
UKMED proforma for submissions
UKMED has developed a proforma for both final and interim reports to support researchers in providing a clear and concise summary of their work. This template is particularly helpful for more extensive or informally structured outputs, such as components of a PhD thesis or interim submissions. Submissions formatted for journal publication will continue to be accepted. We kindly ask that all reports >3,000 words utilise this proforma for submission.
Review outcomes
The Research Subgroup Chair will make the final decision on each output. We will provide you with a response after the review date shown in the table above.
The following final decisions will be made following the review:
| Required changes |
Reviewers have identified areas that require revisions essential for correctness. The final report must undergo further review by the subgroup after the revision. Depending on the nature of the changes, the revised report will either be considered at the next scheduled review meeting or, where appropriate, reviewed by the Chairs. In the latter case, please allow up to 10 working days for this process. |
| Suggested changes recommended | Reviewers have suggested some enhancements that could improve the final report. No further review by the Research Subgroup is required. |
| Approved | The output from the final report is cleared for publication in conferences/the manuscript is released for submission to a journal. |
Once your report is approved, we require a confidential copy of your paper to be submitted at least 30 days prior to any intended publication. This allows us to circulate it to the UKMED Strategy Board for awareness.
Conferences and poster presentations
If the interim report is approved, you may proceed with presenting your findings at conferences or through poster presentations.
However, if there are any outstanding required or recommended changes, these must be addressed and incorporated into the materials to be presented. The revised report will then be reviewed at the next available review window. Please note that the Research Subgroup reserves the right to withhold approval for the presentation of inaccurate or flawed findings at conferences or poster presentations.